We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The annual flu letter describes the national flu immunisation programme and outlines which groups are eligible for flu vaccination.
Information on managing and monitoring a large abdominal aortic aneurysm (AAA) identified through screening.
These leaflets, in English, French, Bengali and Urdu, can help healthcare professionals speak with people about sickle cell disease.
An overview of the 20-week screening scan end-to-end pathway.
A protocol and framework for AAA screening, to establish consistent tests for all subjects: includes a scope of practice for screening technicians.
Visual description of the abdominal aortic aneurysm (AAA) screening pathway.
This publication provides guidance on routine quality control tests for tomosynthesis systems carried out by medical physics services.
Outlines high-risk HPV tests the NHS Cervical Screening Programme (NHSCSP) considers acceptable for use, in primary HPV screening, HPV triage and test of cure.
Healthcare professionals can use this leaflet to answer parents' common questions on a babies' hearing loss in one ear.
This document explains the guidelines for laboratories screening newborns for cystic fibrosis (CF) in the UK.
This document explains the NHS breast screening programme for women defined as being at high risk of breast cancer.
Instructions on how to submit key performance indicator (KPI) data for the Abdominal Aortic Aneurysm (AAA) Screening Programme.
Guidance for bowel cancer screening providers on using national accessible format letter content to support informed choice.
Guidance for radiologists, radiographic consultant practitioners, breast clinicians and radiographic advanced practitioners undertaking breast screening.
Important information for women whose antenatal screening test shows they have HIV, to help explain their result.
This publication covers all inherited metabolic diseases (IMDs) and incorporates the previous PKU and MCADD laboratory handbooks.
Technical guidelines for healthcare professionals screening women at a higher risk of developing breast cancer.
Advice for prescribers on the risk of misuse of pregabalin and gabapentin, and suggestions for a balanced and rational use of these medicines.
Information for pregnant women to understand what it means to be an alpha zero thalassaemia carrier.
The specification and selection of failsafe batches in the NHS Breast Screening Programme for use by screening office managers and staff.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).